TrialJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2024

Gefapixant as a P2X3 receptor antagonist treatment for obstructive sleep apnea: a randomized controlled trial.

Jonathan A Robbins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.